Biological Hallmarks and Emerging Strategies to Target STAT3 Signaling in Multiple Myeloma
Multiple myeloma (MM) is the second most common hematological malignancy, characterized by an abnormal accumulation of plasma cells in the bone marrow. Signal transducer and activator of transcription 3 (STAT3) is a cytoplasmic transcription factor that modulates the transcription of multiple genes...
Main Authors: | Jianbiao Zhou, Wee-Joo Chng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/6/941 |
Similar Items
-
STAT3: A Promising Therapeutic Target in Multiple Myeloma
by: Phyllis S. Y. Chong, et al.
Published: (2019-05-01) -
Anti-myeloma Effects of Icariin Are Mediated Through the Attenuation of JAK/STAT3-Dependent Signaling Cascade
by: Young Yun Jung, et al.
Published: (2018-05-01) -
Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers
by: Boheng Li, et al.
Published: (2021-10-01) -
Inhibition of STAT3 signaling and induction of SHP1 mediate antiangiogenic and antitumor activities of ergosterol peroxide in U266 multiple myeloma cells
by: Rhee Yun-Hee, et al.
Published: (2012-01-01) -
Is the JAK-STAT Signaling Pathway Involved in the Pathogenesis of Depression?
by: Małgorzata Gałecka, et al.
Published: (2022-04-01)